NL Health Services declares meningococcal disease outbreak in Central Newfoundland

NL Health Services has declared an outbreak of invasive meningococcal disease in Central Newfoundland after three laboratory-confirmed cases were identified in the region.

In a public advisory issued Friday, health officials said Public Health has completed case and contact management procedures and has notified individuals considered close or high-risk contacts.

Those identified as close contacts have been offered vaccination against meningococcal group B disease. Officials emphasized that the overall risk to the general public remains low.

Invasive meningococcal disease is a rare but serious bacterial infection that can cause meningitis, an infection of the lining surrounding the brain and spinal cord, or meningococcemia, a bloodstream infection. Both conditions require immediate medical attention.

The bacteria is spread through close, prolonged face-to-face contact, including kissing, coughing or sneezing, as well as sharing items that come into contact with saliva such as drinks, eating utensils, toothbrushes, cigarettes, vapes and lip balm.

Health officials noted that the disease is not spread through casual contact or simply by being in the same room as an infected person.

Symptoms typically develop between two and 10 days after exposure and may include a high fever, severe headache, stiff neck, vomiting, drowsiness, confusion, irritability and a purplish, bruise-like rash.

Residents are being encouraged to monitor for symptoms and take precautions to reduce the risk of transmission, including practicing good hand hygiene, covering coughs and sneezes and avoiding the sharing of personal items.

Officials say anyone who develops symptoms consistent with invasive meningococcal disease should seek immediate medical attention.

NL Health Services also reminded residents that routine meningococcal vaccinations are available through Newfoundland and Labrador's publicly funded childhood and school immunization programs and remain the most effective protection against common strains of the disease.

Public Health said only individuals who have been directly contacted by health officials are considered close or high-risk contacts and require meningitis B vaccination as a post-exposure measure at this time.